These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11477326)

  • 1. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
    Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
    Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M
    Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.
    Isoherranen N; Yagen B; Woodhead JH; Spiegelstein O; Blotnik S; Wilcox KS; Finnell RH; Bennett GD; White HS; Bialer M
    Br J Pharmacol; 2003 Feb; 138(4):602-13. PubMed ID: 12598414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.
    Shimshoni JA; Yagen B; Wlodarczyk B; Finnell RH; Schurig V; Bialer M
    Epilepsia; 2010 Mar; 51(3):323-32. PubMed ID: 19674061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
    Levi M; Yagen B; Bialer M
    Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
    Isoherranen N; White HS; Klein BD; Roeder M; Woodhead JH; Schurig V; Yagen B; Bialer M
    Pharm Res; 2003 Aug; 20(8):1293-301. PubMed ID: 12948028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
    Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
    Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
    Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Finnell RH; Wlodarczyk BJ; Yavin E; Bialer M
    Epilepsia; 2014 Dec; 55(12):1944-52. PubMed ID: 25442425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
    Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
    Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
    Bialer M
    J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.
    Haj-Yehia A; Bialer M
    Pharm Res; 1989 Aug; 6(8):683-9. PubMed ID: 2510141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].
    Benjelloun G; Blandin K; Fossati P
    Encephale; 2004; 30(4):400-3. PubMed ID: 15538315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
    Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of valpromide in rats and the isolated perfused rat liver.
    Billig H; Ziv E; Bar-On H; Bialer M
    Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus.
    Hen N; Shekh-Ahmad T; Yagen B; McDonough JH; Finnell RH; Wlodarczyk B; Bialer M
    J Med Chem; 2013 Aug; 56(16):6467-77. PubMed ID: 23879329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Yagen B; Bialer M
    Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective pharmacokinetic and pharmacodynamic analysis of a CNS-active sulphamoylphenyl carbamate derivative.
    Bibi D; Shusterman B; Nocentini A; Supuran CT; Bialer M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1078-1082. PubMed ID: 31124389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.